MARISSA RECKER: Open Payments
NPI 1700559309 · GLANDORF, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 27 payments from 13 companies in 2025. Trend: 2023 $89 · 2024 $350 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $119 |
| ABBVIE INC. | 6 | $108 |
| Lilly USA, LLC | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Novo Nordisk Inc | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Abbott Laboratories | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: Auvelity, MOUNJARO, VRAYLAR, XIFAXAN, Wegovy, AIRSUPRA, FARXIGA, FREESTYLE LIBRE 3.
Industry payments across OH — which companies pay providers there.
